XML 37 R7.htm IDEA: XBRL DOCUMENT v3.20.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Class A Common Stock
Common Stock
Class A Common Stock
Treasury Stock
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive Loss
Balance (in shares) at Mar. 31, 2017     155,901,485 (7,013,777)      
Beginning of year at Mar. 31, 2017 $ 584,873   $ 1,559 $ (191,900) $ 302,907 $ 489,384 $ (17,077)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock (in shares)     866,099        
Issuance of common stock 8,907   $ 8   8,899    
Stock options exercised (in shares)     1,261,089        
Stock options exercised 12,095   $ 13   12,082    
Repurchase of common stock (in shares)       (7,568,357)      
Repurchase of common stock (269,557)     $ (269,557)      
Recognition of liability related to future stock option exercises (248)       (248)    
Net income 301,692         301,692  
Other comprehensive loss, net of tax 4,822           4,822
Dividends paid (103,411)         (103,411)  
Stock-based compensation expense 23,318       23,318    
Balance (in shares) at Mar. 31, 2018     158,028,673 (14,582,134)      
End of year at Mar. 31, 2018 562,491   $ 1,580 $ (461,457) 346,958 690,516 (15,106)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock (in shares)     876,187        
Issuance of common stock 11,266   $ 9   11,257    
Stock options exercised (in shares)     1,019,965        
Stock options exercised 12,116   $ 10   12,106    
Repurchase of common stock (in shares)   (5,100,000)   (5,314,838)      
Repurchase of common stock (249,993)     $ (249,993)      
Net income 418,529         418,529  
Other comprehensive loss, net of tax 3,916           3,916
Dividends paid (114,234)         (114,234)  
Stock-based compensation expense 31,275       31,275    
Balance (in shares) at Mar. 31, 2019     159,924,825 (19,896,972)      
End of year at Mar. 31, 2019 675,366   $ 1,599 $ (711,450) 401,596 994,811 (11,190)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock (in shares)     833,258        
Issuance of common stock 14,987   $ 8   14,979    
Stock options exercised (in shares)     575,890        
Stock options exercised 8,925   $ 6   8,919    
Repurchase of common stock (in shares)   (2,500,000)   (2,717,080)      
Repurchase of common stock (186,645)     $ (186,645)      
Recognition of liability related to future restricted stock units vesting (757)       (757)    
Net income 482,603         482,603  
Other comprehensive loss, net of tax (34,811)           (34,811)
Dividends paid (146,602)         (146,602)  
Stock-based compensation expense 43,290       43,290    
Balance (in shares) at Mar. 31, 2020     161,333,973 (22,614,052)      
End of year at Mar. 31, 2020 $ 856,356   $ 1,613 $ (898,095) $ 468,027 $ 1,330,812 $ (46,001)